• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sidoti Events, LLC's Virtual August Micro-Cap Conference

    8/15/23 10:20:00 AM ET
    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Professional Services
    Consumer Discretionary
    Get the next $ANEB alert in real time by email

    NEW YORK, NY / ACCESSWIRE / August 15, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.

    Sidoti & Company, LLC, Monday, August 14, 2023, Press release picture

    Presentation Schedule

    *All Times EST

    Wednesday, August 16, 2023 (Day 1)

    8:30-9:00

    Ohmyhome Ltd. (OMH)

    Hookipa Pharma Inc. (HOOK)

    *****

    9:15-9:45

    Loop Industries (LOOP)

    Zomedica Inc (ZOM)

    LEE Enterprises, Inc. (LEE)

    10:00-10:30

    Mativ Holdings, Inc. (MATV)

    DLH Holdings (DLHC)

    T2 Biosystems, Inc. (TTOO)

    10:45-11:15

    Near Intelligence (NIR)

    Surmodics Inc. (SRDX)

    L.B. Foster Company (FSTR)

    11:30-12:00

    IDACORP, Inc (IDA)

    Harvard Bioscience (HBIO)

    Citizens, Inc. (CIA)

    12:15-12:45

    Independence Contract Drilling (ICD)

    Personalis (PSNL)

    Silvercrest Asset Management Group Inc. (SAMG)

    1:00-1:30

    Ideal Power (IPWR)

    Anebulo Pharmaceuticals (ANEB)

    GEE Group (JOB)

    1:45-2:15

    Powell Industries, Inc. (POWL)

    MAIA Biotechnology, Inc. (MAIA)

    Rocky Mountain Chocolate (RMCF)

    2:30-3:00

    Innovative Solutions & Support (ISSC)

    Hillstream BioPharma, Inc. (HILS)

    Super League Gaming, Inc (SLGG)

    3:15-3:45

    Unisys Corporation (UIS)

    Markforged (MKFG)

    CaliberCos Inc. (CWD)

    4:00-4:30

    Sonim Technologies (SONM)

    KLX Energy Services Holdings (KLXE)

    Comstock Inc (LODE)

    1x1s Only

    (16th)

    DevvStream Inc. (DSTRF)

    Hall of Fame Resort & Entertainment Co. (HOFV)

    Paysign, Inc. (PAYS)

    *****

    *****

    *****

    *All Times EST

    Thursday, August 17, 2023 (Day 2)

    8:30-9:00

    *****

    AGBA Group (AGBA)

    *****

    9:15-9:45

    MtronPTI (MPTI)

    The Real Brokerage Inc (REAX)

    Splash Beverage Group (SBEV)

    10:00-10:30

    CLIQ Digital AG (CLIQ)

    LifeMD (LFMD)

    Mistras Group (MG)

    10:45-11:15

    Innovative Eyewear, Inc. (LUCY)

    CareCloud (CCLD)

    Granite Construction Inc. (GVA)

    11:30-12:00

    Shapeways (SHPW)

    Processa Pharmaceuticals (PCSA)

    Landsea Homes (LSEA)

    12:15-12:45

    *****

    Modular Medical (MODD)

    Sidus Space (SIDU)

    1:00-1:30

    Daktronics (DAKT)

    Kala Pharmaceuticals (KALA)

    Terran Orbital (LLAP)

    1:45-2:15

    SOBR Safe Inc. (SOBR)

    Xcel Brands (XELB)

    SYLA Technologies (SYT)

    2:30-3:00

    Intellicheck (IDN)

    Alpha Teknova, Inc. (TKNO)

    ClearOne, Inc. (CLRO)

    3:15-3:45

    AudioEye Inc (AEYE)

    Quince Therapeutics (QNCX)

    Astra Space (ASTR)

    4:00-4:30

    Iteris, Inc. (ITI)

    *****

    ARC Document Solutions (ARC)

    1x1s Only

    (17th)

    Hall of Fame Resort & Entertainment Co. (HOFV)

    Kelly Services, Inc. (KELYA)

    Paysign, Inc. (PAYS)

    Tennant Company (TNC)

    *****

    *****

    About Sidoti Events, LLC ("Events") and Sidoti & Company, LLC ("Sidoti")
    In 2023, Sidoti & Company, LLC (www.sidoti.com) formed a sister company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the nearly 25 years of experience Sidoti had as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 160 equities of which around 40 percent participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. Events is a leading provider of corporate access through the eight investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Event's benefits from Sidoti's small- and microcap-focused nationwide sales force, which has connections with 1,500 institutional relationships in North America. This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

    SOURCE: Sidoti Events, LLC and Sidoti & Company, LLC



    View source version on accesswire.com:
    https://www.accesswire.com/774189/Sidoti-Events-LLCs-Virtual-August-Micro-Cap-Conference

    Get the next $ANEB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANEB
    $DLHC
    $HBIO
    $HOOK

    CompanyDatePrice TargetRatingAnalyst
    Powell Industries Inc.
    $POWL
    1/23/2026$427.00Neutral
    Cantor Fitzgerald
    IDACORP Inc.
    $IDA
    1/20/2026$118.00Equal Weight → Underweight
    Wells Fargo
    IDACORP Inc.
    $IDA
    1/14/2026$144.00Overweight
    Barclays
    IDACORP Inc.
    $IDA
    12/16/2025$139.00Equal-Weight → Overweight
    Morgan Stanley
    Unisys Corporation New
    $UIS
    12/10/2025Outperform
    William Blair
    Innovative Solutions and Support Inc.
    $ISSC
    12/5/2025$16.00Buy
    Craig Hallum
    Personalis Inc.
    $PSNL
    12/2/2025$11.00Equal-Weight
    Morgan Stanley
    Innovative Solutions and Support Inc.
    $ISSC
    11/21/2025$16.50Outperform
    Northland Capital
    More analyst ratings

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    SEC Filings

    View All

    DLH Holdings Corp. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - DLH Holdings Corp. (0000785557) (Filer)

    3/17/26 5:06:38 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    SEC Form DEFA14A filed by Mativ Holdings Inc.

    DEFA14A - Mativ Holdings, Inc. (0001000623) (Filer)

    3/17/26 4:48:37 PM ET
    $MATV
    Paper
    Basic Materials

    SEC Form DEF 14A filed by Mativ Holdings Inc.

    DEF 14A - Mativ Holdings, Inc. (0001000623) (Filer)

    3/17/26 4:46:29 PM ET
    $MATV
    Paper
    Basic Materials

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Powell Inds with a new price target

    Cantor Fitzgerald initiated coverage of Powell Inds with a rating of Neutral and set a new price target of $427.00

    1/23/26 8:20:35 AM ET
    $POWL
    Electrical Products
    Energy

    IdaCorp downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded IdaCorp from Equal Weight to Underweight and set a new price target of $118.00

    1/20/26 9:09:08 AM ET
    $IDA
    Electric Utilities: Central
    Utilities

    Barclays initiated coverage on IdaCorp with a new price target

    Barclays initiated coverage of IdaCorp with a rating of Overweight and set a new price target of $144.00

    1/14/26 8:41:49 AM ET
    $IDA
    Electric Utilities: Central
    Utilities

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Duke John D bought $25,050 worth of shares (5,000 units at $5.01), increasing direct ownership by 5% to 105,000 units (SEC Form 4)

    4 - HARVARD BIOSCIENCE INC (0001123494) (Issuer)

    3/17/26 5:56:45 PM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    President and CEO Somo David M bought $250,000 worth of shares (90,909 units at $2.75), increasing direct ownership by 37% to 338,347 units (SEC Form 4)

    4 - Ideal Power Inc. (0001507957) (Issuer)

    2/26/26 8:49:32 AM ET
    $IPWR
    Semiconductors
    Technology

    Large owner Mink Brook Asset Management Llc bought $44,264 worth of shares (8,048 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    2/20/26 4:31:07 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Denelsky Stephen J

    4 - HARVARD BIOSCIENCE INC (0001123494) (Issuer)

    3/18/26 2:13:07 PM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 3 filed by new insider Liu Wen Tao (Wt)

    3 - Ohmyhome Ltd (0001944902) (Issuer)

    3/18/26 8:30:02 AM ET
    $OMH
    Real Estate
    Finance

    SEC Form 4 filed by Snider William

    4 - HARVARD BIOSCIENCE INC (0001123494) (Issuer)

    3/18/26 7:31:56 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption

    Dr. Chen expands his leadership role to serve as President while continuing to serve as Chief Medical Officer (CMO), unifying R&D innovation with operational execution as Personalis defines the next era of ultrasensitive MRD testing Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, today announced the promotion of Richard Chen, M.D., M.S., to the position of President. Dr. Chen will continue to serve as CMO of Personalis in addition to his new role. The appointment comes at a critical inflection point as Personalis transitions from a pioneering R&D powerhouse into a market leader in Minimal Residual Disease (MRD) testing. Under Dr. Chen's scientific l

    3/17/26 4:00:00 PM ET
    $PSNL
    Medical Specialities
    Health Care

    Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results

    Fourth Quarter 2025 Revenues of $23.7M and Gross Margin of 59.7%Full Year 2025 Revenues of $86.6M and Gross Margin of 57.7%Interim CFO Mark Frost Appointed CFO on Permanent BasisIntroduces Full Year 2026 Guidance which Reflects Anticipated Revenue Growth Driven by New Products for Translational Science HOLLISTON, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience") today announced financial results for the fourth quarter and full year ended December 31, 2025. "2025 was a pivotal year for Harvard Bioscience as we strengthened our balance sheet and streamlined our operating model. This culminated in fourth quarter results

    3/12/26 7:30:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal®

    Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, today announced the publication of the PREDICT-DNA study in the Journal of Clinical Oncology. The article, "The Pathologic Response Evaluation and Detection In Circulating Tumor-DNA (PREDICT-DNA) study: Ultrasensitive ctDNA Assessment of Breast Cancer Minimal Residual Disease," showed that ultrasensitive molecular residual disease (MRD) testing with NeXT Personal can perform better than current standard approaches in predicting patient outcomes following neoadjuvant therapy (NAT). The prospective study followed 227 patients with Triple-Negative (TNBC) and HER2+ breast cancer across more than 24 leading U

    3/12/26 6:00:00 AM ET
    $PSNL
    Medical Specialities
    Health Care

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Leadership Updates

    Live Leadership Updates

    View All

    Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption

    Dr. Chen expands his leadership role to serve as President while continuing to serve as Chief Medical Officer (CMO), unifying R&D innovation with operational execution as Personalis defines the next era of ultrasensitive MRD testing Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, today announced the promotion of Richard Chen, M.D., M.S., to the position of President. Dr. Chen will continue to serve as CMO of Personalis in addition to his new role. The appointment comes at a critical inflection point as Personalis transitions from a pioneering R&D powerhouse into a market leader in Minimal Residual Disease (MRD) testing. Under Dr. Chen's scientific l

    3/17/26 4:00:00 PM ET
    $PSNL
    Medical Specialities
    Health Care

    Diality Appoints Peter Donato as Chief Financial Officer

    Life sciences veteran brings private and public sector expertise to company in midst of growth trajectory Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System while preparing for a limited market release in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224064413/en/Diality CFO Peter Donato. Donato joins Diality with nearly 35 years of financial leadershi

    2/24/26 7:05:00 AM ET
    $MYGN
    $STIM
    $TFX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Medical/Dental Instruments
    Pharmaceuticals and Biotechnology

    Innovative Aerosystems Acquires Moog' S-TEC® Model 3100 Autopilot Product Line, Expanding Flight Control Portfolio

    Innovative Aerosystems (NASDAQ:ISSC) today announced it closed the acquisition of the Moog (NYSE:MOG) S-TEC® Model 3100 general aviation fixed wing autopilot product line, further strengthening the company's position as a leading provider of advanced avionics, flight control, and mission-critical aerospace systems for commercial, business, and military aircraft. The acquisition expands Innovative Aerosystems' integrated flight control capabilities and enhances its ability to deliver modernized, mission-ready solutions across both legacy and next-generation platforms. By incorporating the proven autopilot technology into its growing portfolio, the company will provide customers with greate

    2/23/26 8:30:00 AM ET
    $ISSC
    $MOG
    EDP Services
    Technology

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by HOOKIPA Pharma Inc.

    SC 13G/A - HOOKIPA Pharma Inc. (0001760542) (Subject)

    11/14/24 6:07:08 PM ET
    $HOOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Surmodics Inc.

    SC 13G/A - SURMODICS INC (0000924717) (Subject)

    11/14/24 3:36:00 PM ET
    $SRDX
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by IDACORP Inc.

    SC 13G/A - IDACORP INC (0001057877) (Subject)

    11/14/24 1:28:29 PM ET
    $IDA
    Electric Utilities: Central
    Utilities

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Financials

    Live finance-specific insights

    View All

    Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results

    Fourth Quarter 2025 Revenues of $23.7M and Gross Margin of 59.7%Full Year 2025 Revenues of $86.6M and Gross Margin of 57.7%Interim CFO Mark Frost Appointed CFO on Permanent BasisIntroduces Full Year 2026 Guidance which Reflects Anticipated Revenue Growth Driven by New Products for Translational Science HOLLISTON, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience") today announced financial results for the fourth quarter and full year ended December 31, 2025. "2025 was a pivotal year for Harvard Bioscience as we strengthened our balance sheet and streamlined our operating model. This culminated in fourth quarter results

    3/12/26 7:30:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Powell Industries Announces Three-For-One Stock Split

    HOUSTON, March 06, 2026 (GLOBE NEWSWIRE) -- Powell Industries, Inc. (NASDAQ:POWL) announced today that its Board of Directors has approved a three-for-one forward stock split of the Company's common stock. The Board of Directors also approved a proportionate increase in the number of authorized shares of common stock to accommodate the stock split. The split will be effected through an amendment to the Company's Amended and Restated Certificate of Incorporation. Each shareholder of record as of the close of trading on March 20, 2026 (the "record date") will receive, after the close of trading on April 2, 2026, two additional shares for every one share held on the record date. Subject to fi

    3/6/26 4:01:00 PM ET
    $POWL
    Electrical Products
    Energy

    Ideal Power to Host Fourth Quarter and Full Year 2025 Results Conference Call on March 10, 2026 at 10:00 AM Eastern Time

    AUSTIN, Texas, Feb. 27, 2026 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, today announced management will hold a conference call on Tuesday, March 10, 2026 at 10:00 AM Eastern Time to discuss its results for the fourth quarter and full year ended December 31, 2025. A press release detailing these results will be issued prior to the call.Ideal Power management will host the conference call, followed by a question-and-answer period. Analysts and investors may pose questions for management during the live conference call on March 1

    2/27/26 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology